Table 3.

Characteristics of screening discussions (weighted percentages)^*

Variable	Prostate cancer N = 198	Colorectal cancer men N =258	Colorectal cancer women N = 355	Breast cancer N = 460	P-value†
Decision processes
Test was part of plan to get screened regularly	87.8	84.2	71.9	94.4	<0.001
Person raising idea of getting screened					0.001
Participant	35.8	23.4	16.5	19.3
Health care provider	64.2	76.6	83.5	80.7
Discussed screening with > 1 health care provider	29.1	30.0	27.0	36.8	0.24
Seeking a second opinion	51.1	17.2	16.4	19.1	<0.01
Health care provider asked participant about screening preferences	56.7	41.0	31.1	45.2	<0.001
Final decision maker on whether to have screening					0.13
Participant	32.1	47.1	37.7	40.2
Health care provider	6.5	1.6	3.8	4.9
Shared	61.5	51.3	58.6	54.9
Communication
Discussed pros of screening with health care provider					0.03
A lot	40.1	36.0	40.1	49.9
Some/a little	54.1	61.8	57.4	46.4
Not at all	5.8	2.2	2.5	3.8
Discussed cons of screening with health care provider					0.20
A lot	4.1	5.1	6.5	6.4
Some/a little	25.5	22.3	19.7	13.1
Not at all	70.4	72.6	73.8	80.5
Reasons for screening explained well by health care provider	84.4	87.2	93.8	88.6	0.02
Health care provider had opinion about screening	85.2	91.2	84.6	84.5	0.17
Health care provider recommendation					<0.001
For screening	72.9	90.2	77.7	82.5
Against screening	1.3	0.1	3.9	0.3
No opinion/other	25.8	9.6	18.4	17.2
Screening Decisions
Underwent screening following discussion	86.0	78.9	70.4	90.4	<0.001
Confidence in screening decision					<0.0001
0 (“not at all”)	0.4	1.9	4.1	2.1
1–3	0.7	0.4	6.3	0.8
4–7	9.4	13.8	10.4	4.0
8–9	30.6	20.9	15.3	8.4
10 (“extremely”)	58.9	63.0	63.8	84.7
Preferred amount of involvement in screening decision					0.10
Less	2.4	1.2	2.9	2.6
Same	81.2	93.7	85.2	89.6
More	16.4	5.1	11.9	7.8

^*Column percentages may not sum to 100% due to rounding

^†P-values reflect overall chi-squared tests of proportions across the four decision groups